Jun Wang

Dr. Jun Wang is an assistant professor at the Department of Pathology and the Laura and Isaac Perlmutter Cancer Center of NYU Langone health. Dr. Wang has been working on cancer immunology and immunotherapy for over 15 years. He is a pioneer in anti-41BB liver toxicity mechanisms, as well as the characterization of novel immune receptor-ligand pathways using genome-scale screening platforms, with which he discovered several first-in-class targets such as FGL1/LAG-3 and Siglec-15 for cancer immunotherapy.